Compile Data Set for Download or QSAR
Report error Found 127 Enz. Inhib. hit(s) with all data for entry = 2055
TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351810(US9796716, Compound 64 | US9796716, Compound 54)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351820(US9796716, Compound 65)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351817(US9796716, Compound 62)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351818(US9796716, Compound 63)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351823(US9796716, Compound 68)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351824(US9796716, Compound 69)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351821(US9796716, Compound 66)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351822(US9796716, Compound 67)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351811(US9796716, Compound 55)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351812(US9796716, Compound 57)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351809(US9796716, Compound 53)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351810(US9796716, Compound 64 | US9796716, Compound 54)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351815(US9796716, Compound 60)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351816(US9796716, Compound 61)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351813(US9796716, Compound 58)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351814(US9796716, Compound 59)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351837(US9796716, Compound 80)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351838(US9796716, Compound 81)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351835(US9796716, Compound 78)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351836(US9796716, Compound 79)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351841(US9796716, Compound 84)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351842(US9796716, Compound 85)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351839(US9796716, Compound 82)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351840(US9796716, Compound 83)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351828(US9796716, Compound 72)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351829(US9796716, Compound 73)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351825(US9796716, Compound 70)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351826(US9796716, Compound 75 | US9796716, Compound 71)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351833(US9796716, Compound 76)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351834(US9796716, Compound 77)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351831(US9796716, Compound 74)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351826(US9796716, Compound 75 | US9796716, Compound 71)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351853(US9796716, Compound 98)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351854(US9796716, Compound 99)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351851(US9796716, Compound 96)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351852(US9796716, Compound 97)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351857(US9796716, Compound 102)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351858(US9796716, Compound 103)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351855(US9796716, Compound 100)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351856(US9796716, Compound 101)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351845(US9796716, Compound 88)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351846(US9796716, Compound 90)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351843(US9796716, Compound 86)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351844(US9796716, Compound 87)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351849(US9796716, Compound 93)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351850(US9796716, Compound 95)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351847(US9796716, Compound 91)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351848(US9796716, Compound 92)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351869(US9796716, Compound 114)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351870(US9796716, Compound 115)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

Displayed 1 to 50 (of 127 total ) | Next | Last >>
Jump to: